Kitamoto Takumi, Suematsu Sachiko, Yamazaki Yuto, Nakamura Yasuhiro, Sasano Hironobu, Matsuzawa Yoko, Saito Jun, Omura Masao, Nishikawa Tetsuo
Endocrinology and Diabetes Center (T.K., S.S., Y.M., J.S., M.O., T.N.), Yokohama Rosai Hospital, Yokohama 222-0036, Japan; and Department of Pathology (Y.Y., Y.N., H.S.), Tohoku University School of Medicine, Sendai 980-8575, Japan.
J Clin Endocrinol Metab. 2016 Feb;101(2):494-503. doi: 10.1210/jc.2015-3284. Epub 2015 Nov 25.
This comparative study clarified the clinical characteristics and in vitro steroidogenic activities of aldosterone-producing adenomas (APAs) harboring ATPase or CACNA1D gene mutations.
Genetic testing was performed on 159 unilateral APAs. Somatic ATPase and CACNA1D gene mutations were analyzed in 42 APA tissues without KCNJ5 gene mutations.
ATP1A1, ATP2B3, and CACNA1D mutations were detected in one, four, and four patients, respectively. Compared with patients without KCNJ5, ATPase, or CACNA1D mutations (wild type), ATPase mutations tended to have more severe hyperaldosteronism and smaller tumors; those with CACNA1D mutations had clinical characteristics and tumor sizes similar to those with wild-type genes. APAs with ATPase mutations were composed mainly of compact eosinophilic tumor cells, whereas CACNA1D mutations resulted in predominantly clear tumor cells. Aldosterone production in APA cells with ATP2B3 mutations were more responsive to dibutyryl cAMP, whereas those with CACNA1D mutations were more responsive to adrenocorticotropic hormone than the wild-type cells.
APAs with ATPase mutations demonstrated a potentially severe primary aldosteronism phenotype, whereas those with CACNA1D mutations displayed characteristics similar to wild-type APAs. The status of stimulated aldosterone production was also different according to the cell types, suggesting that the regulatory effects of adrenocorticotropic hormone on aldosterone synthesis could possibly vary according to the intracellular signaling involved in hormone production.
本比较研究阐明了携带ATP酶或CACNA1D基因突变的醛固酮瘤(APA)的临床特征和体外类固醇生成活性。
对159例单侧APA进行基因检测。在42例无KCNJ5基因突变的APA组织中分析体细胞ATP酶和CACNA1D基因突变。
分别在1例、4例和4例患者中检测到ATP1A1、ATP2B3和CACNA1D基因突变。与无KCNJ5、ATP酶或CACNA1D基因突变(野生型)的患者相比,ATP酶基因突变患者往往有更严重的醛固酮增多症且肿瘤较小;CACNA1D基因突变患者的临床特征和肿瘤大小与野生型基因患者相似。ATP酶基因突变的APA主要由致密嗜酸性肿瘤细胞组成,而CACNA1D基因突变则主要导致透明肿瘤细胞。ATP2B3基因突变的APA细胞中醛固酮生成对二丁酰环磷腺苷更敏感,而CACNA1D基因突变的APA细胞中醛固酮生成对促肾上腺皮质激素比野生型细胞更敏感。
ATP酶基因突变的APA表现出潜在的严重原发性醛固酮增多症表型,而CACNA1D基因突变的APA表现出与野生型APA相似的特征。根据细胞类型,刺激醛固酮生成的状态也不同,这表明促肾上腺皮质激素对醛固酮合成的调节作用可能因激素产生所涉及的细胞内信号传导而异。